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Abstract
Background: Micronodular lesions are common findings in lung imaging. As an important differential diagnosis,
we describe a case of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia; it is notable that the diagnosis
of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia is often delayed. This case provides supporting
evidence to establish lung biopsy by cryotechnique as the option of first choice when considering a diagnostic
strategy for micronodular lung lesions.
Case presentation: We report a case of a 65-year-old white woman who presented with obstructive symptoms of
chronic coughing and dyspnea confirmed by conventional lung function tests. A computed tomography scan
presented disseminated micronodules in all the lobes of her lungs. With the help of bronchoscopic cryobiopsy it
was possible to obtain a high yield sample of lung parenchyma. On histologic examination, the micronodules
correlated with a diffuse neuroendocrine cell hyperplasia. In the context of clinical symptoms, radiological aspects,
and histomorphological aspects we made the diagnosis of a diffuse idiopathic pulmonary neuroendocrine cell
hyperplasia. Obstructive symptoms were treated with inhaled steroids and beta-2-mimetics continuously. A
comparison between current computed tomography scans of our patient and scans of 2014 revealed no significant
changes. Last ambulatory checks occurred in January and May of 2016. The course of disease and the extent of
limitation of lung function have remained stable.
Conclusions: The diagnosis of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia is best made in a
multidisciplinary review including clinical presentation, lung imaging, and histomorphological aspects. This report
and current literature indicate that transbronchial lung cryobiopsy can be used as a safe and practicable tool to
obtain high quality biopsies of lung parenchyma in order to diagnose micronodular lesions of the lung.
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Background
Diffuse idiopathic pulmonary neuroendocrine cell
hyperplasia (DIPNECH) is a rare idiopathic disease,
which was named by Aguayo et al.; it is associated
with neuroendocrine cell hyperplasia and obliterative
bronchiolitis [1]. Patients are typically older women and
non-tobacco smokers who are affected by obstructive
symptoms such as coughing and dyspnea [2]. On histo-
logic examination, DIPNECH presents as a scattered
nodular or linear proliferation of neuroendocrine cells
either superficial to the basement membrane of bron-
chial or bronchiolar epithelium or in the form of
tumorlets beyond it. Tumorlets are neuroendocrine
cell proliferates smaller than 5 mm in diameter. The
World Health Organization defines DIPNECH as a
praeneoplastic condition. Patients may develop syn-
chronous or subsequent carcinoid tumors, which
measure more than 5 mm whereas tumorlets measure
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less than 5 mm [3, 4]. DIPNECH is known to have a
good prognosis. Most cases show stability in symp-
toms and radiological findings. Therefore a watch and
wait strategy seems the method of choice. However, a
few patients show rapid clinical progression [2]. In
cases of progressive disease a surgical excision of
dominant lesions and somatostatin analogs may be con-
sidered a therapy option [5]. Similar to other obstructive
lung diseases, complications such as acute exacerbation
including bronchitis and pneumonia can occur. A stand-
ard procedure in diagnostic strategy and therapy of DIP-
NECH has not yet been established.
Case presentation
In November 2014, a 65-year-old white woman with a
history of progressive dyspnea presented to our hospital
for evaluation. She complained about dyspnea on exer-
tion and had had several infectious exacerbations of
chronic obstructive pulmonary disease (COPD) during
the last year, one requiring hospitalization. During those
exacerbations she had been treated with tapering doses
of systemic corticosteroids showing improvement in
hypoxemia and obstructive symptoms. At the point of
presentation her medication for inhalation included:
budesonide/formoterol 400 μg/12 μg twice a day, tiotro-
pium bromide 18 μg once a day, and salbutamol as
needed, which she was using at least once a day. Her
general patient history was negative for atopic diseases
or allergies. At the age of 54 she was diagnosed as hav-
ing COPD due to dyspnea and typical lung function
tests. She stated that she had never smoked tobacco. A
skin prick test revealed no hypersensitivity. Since the
diagnosis of COPD had been established she was regu-
larly followed-up by a pulmonologist. At hospital admis-
sion, her general condition was slightly disturbed. She
was hypoxic at rest. The saturation level of oxygen in
hemoglobin (SaO2) was 92%, without providing indica-
tion for oxygen therapy.
A body plethysmography showed forced vital capacity
(FVC) 1.47 L (62%), forced expiratory volume in 1 sec-
ond (FEV1) of 0.8 L (40%), airway resistance of 1.62 kPa
× second/L (538.9%), residual volume of 3.30 L (188%),
and a total lung capacity of 4.50 L (108%). Those results
were evaluated as severe obstruction with massive air
trapping compatible with the diagnosis of COPD. During
the further evaluation process different methods of
imaging were conducted. A chest X-ray showed well-
ventilated lungs and discreet apical pleural callosity.
Transthoracic echocardiography showed normal cardiac
structures without evidence of pulmonary hypertension.
In a computed tomography (CT) scan, disseminated
small nodules between 2 and 4 mm in all lobes, ground
glass characteristic, and partial mosaicism on both lungs
were strikingly apparent. Focal bronchial thickening
could be seen. Furthermore, mediastinal lymph nodes
were heightened (Fig. 1).
As a result of lung imaging, bronchoscopy was initi-
ated. Forceps biopsies of her central airways were taken,
showing normal respiratory mucosa without any changes
suspicious for a specific inflammation. In particular,
granulomas or giant cells could not be detected. Due to
ongoing clinical suspicion for interstitial lung disease a
further attempt of forcing a histological diagnosis was
made.
By method of transbronchial cryobiopsy (ERBE-
CRYO2, diameter 1.9 mm; Tübingen, Germany), lung
tissue samples of the middle and inferior lobes of her
right lung were gained. The material was formalin fixed
and paraffin embedded, cut into 4 μm-thick sections and
stained with hematoxylin and eosin (H&E). The frag-
mented biopsy measured an overall area of 30.9 mm2
compared with the initial biopsy of 7.5 mm2 (Mirax
Viewer Image Software Version 1.12, Zeiss Microima-
ging, Oberkochen, Germany and 3D Tech, Budapest,
Hungary). Besides small airways, a regular lung paren-
chyma with an alveolar basic structure could be seen.
The bronchioles were lined by a regular respiratory epi-
thelium. Furthermore, in her bronchiolic mucosa, linear
and nodular proliferates of small uniform cells with
round to slightly ovoid nuclei and disperse chromatin
were located within the epithelial basement membrane
and bulged into the lumina (Fig. 2). Peribronchiolar and
perivascular aggregates of cells showing this morphology
were also found, measuring less than 5 mm in diameter
at maximum. No signs of malignancy could be found;
neither could we find any mitotic activity, desmoplastic
stroma reaction, or any invasive aspect. In association
with the described cell cluster, slight fibrosis could be
Fig. 1 Axial image from chest computed tomography scan showing
multiple scattered pulmonary nodules and mosaicism
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seen. In the Elastica van Gieson stain, the walls of some
bronchioles were broadened and contained an increased
amount of elastic fibers. Immunostainings revealed
strong positivity for synaptophysin (Fig. 3), chromogra-
nin A, and CK7 in the cell cluster described. The prolif-
erative index determined by Ki67% (Mib-1) was beneath
1% (antibodies by Roche, Rotkreuz, Switzerland). Based
on these findings, the diagnosis of a neuroendocrine cell
hyperplasia could be made and a possible association
with DIPNECH was noted.
Due to concomitant bronchitis our patient received
antibiotic therapy. Obstructive symptoms were treated
with inhaled steroids and beta-2-mimetics continuously.
Comparing current CT scans of our patient with scans
in 2014 no significant changes are described. Last ambu-
latory checks occurred in January and May of 2016. The
course of disease and the extent of limitation of lung
function have remained stable.
Discussion
On the background of clinical presentation and lung im-
aging the microscopic morphology is compatible with a
manifestation of DIPNECH. Our patient presented has
gone through a history of obstructive lung disease in-
cluding symptoms like exertional dyspnea with slight re-
lief under anti-obstructive therapy. Also, lung function
tests have repeatedly shown severe obstruction. In com-
parison to a typical patient who has COPD, our patient
does not have a history of tobacco smoking. In the past
and recent literature, DIPNECH has been described to
be potentially associated with obliterative bronchiolitis
and respectively could be the cause of chronic obstruc-
tion [1, 2, 6, 7].
On histologic examination, the wall of her bronchioles
were thickened and showed a linear and nodular neuro-
endocrine cell hyperplasia, in which an incomplete oblit-
eration of these airways could be shown by cell bulging
into the airway lumen. However, the complete morpho-
logical picture of an obstructive bronchiolitis is not com-
prised in the obtained biopsy. However, it can easily be
imagined that even an incomplete obliteration of bron-
chioles can cause obstruction comparable to symptoms
induced by a follicular bronchiolitis, in which prominent
lymphatic tissue obliterates bronchiolic lumina. Further-
more, broncho-obstruction can be caused or at least
aggravated by different vasomodulating and bronchomo-
dulating peptides produced in hyperplastic/neoplastic
pulmonary neuroendocrine cells [8]. Any of these
changes may have caused the obstructive symptoms of
this patient, including typical lung function tests, poten-
tially leading to earlier diagnoses of chronic obstructive
lung disease or intrinsic asthma. In this regard, it is not-
able that the final diagnosis of DIPNECH is often de-
layed [7].
Micronodular lesions of the lung can be coincidental
diagnostic findings in lung imaging. Also, DIPNECH is
sometimes asymptomatic and may be diagnosed acci-
dentally [2]. To consider different courses of disease the
term “DIPNECH syndrome” has been proposed [9]. In
CT imaging DIPNECH can present not only with mul-
tiple small nodules in both lungs but also with bronchial
wall thickening and mosaic perfusion [10]. Rare radio-
logical findings include fibrotic changes comparable to a
restrictive pattern in usual interstitial pneumonia [11].
In addition to lung imaging, surgical lung biopsies are
usually required to diagnose DIPNECH and correspond-
ing obliterative bronchiolitis [6]. Any other symptomatic
or asymptomatic micronodular lesion, for example
sarcoidosis, usually requires an open lung biopsy to be
clarified as well. Further diagnostic tools like an octreo-
tide scan and positron emission tomography (PET)-CT
are also helpful. Blood examinations might reveal ele-
vated serum levels of chromogranin A [5].
Fig. 2 Hematoxylin and eosin stained slide shows bronchiole with
linear and nodular proliferates of neuroendocrine cells bulging into
the lumen
Fig. 3 Strong positivity in immunohistochemical analysis
with synaptophysin
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In this special case, transbronchial cryobiopsy was
used to obtain a good quality biopsy of lung parenchyma
from which it was possible to generate the diagnosis of
DIPNECH. This method has an advantage over the use
of conventional transbronchial forceps because alveolar
tissue is contained more often and shows fewer crush ar-
tefacts [12, 13]. Besides, the cryotechnique method
seems safer and less straining for patients compared to
open biopsy methods [14]. The risk of significant bleed-
ing in transbronchial cryobiopsy does not differ from
that of using conventional forceps [15]. In particular,
concerning histomorphological analysis of interstitial
lung diseases, the cryotechnique can be used in combin-
ation with flexible catheters to reach peripheral areas of
the lung [16]. Transbronchial cryobiopsy has a particu-
larly good diagnostic yield for diseases diffusely involving
the lung parenchyma [17, 18]. In summary, transbron-
chial cryobiopsy can be regarded as an ideal method for
diagnosing DIPNECH.
Conclusions
The diagnosis of DIPNECH is best made in a multidiscip-
linary review including clinical presentation, lung imaging,
and histomorphological aspects. Current literature indi-
cates that transbronchial lung cryobiopsy can be used as a
safe and practicable tool to obtain high quality biopsies
of lung parenchyma in order to diagnose micronodular
lesions of the lung. Therefore, this case provides sup-
porting evidence to establish lung biopsy by cryotechni-
que as the option of first choice before using surgical
biopsy techniques.
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